Analysis of Profitability Ratios
Quarterly Data
Profitability ratios measure the company ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
AmerisourceBergen Corp., profitability ratios (quarterly data)
Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31).
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | AmerisourceBergen Corp. gross profit margin ratio deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | AmerisourceBergen Corp. operating profit margin ratio deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | AmerisourceBergen Corp. net profit margin ratio deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023. |
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | AmerisourceBergen Corp. ROA deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023. |
Gross Profit Margin
AmerisourceBergen Corp., gross profit margin calculation (quarterly data)
| Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||||||||
| Gross profit | 2,264,646) | 2,295,442) | 2,145,953) | 1,985,559) | 2,015,369) | 2,235,080) | 2,060,359) | 2,069,411) | 1,888,206) | 1,533,381) | 1,452,230) | 1,346,847) | 1,225,716) | 1,388,107) | 1,231,214) | 1,184,737) | 1,231,239) | 1,424,756) | 1,297,580) | 1,032,641) | 1,211,341) | 1,255,683) | 1,112,652) | 1,172,020) | 1,079,875) | 1,256,427) | 1,037,680) | ||||||||
| Revenue | 66,947,043) | 63,457,205) | 62,846,832) | 61,174,149) | 60,064,601) | 57,719,446) | 59,628,810) | 58,912,421) | 53,405,695) | 49,154,171) | 52,516,556) | 49,244,768) | 45,366,777) | 47,417,639) | 47,864,742) | 45,637,802) | 45,239,265) | 43,319,602) | 45,392,452) | 43,297,136) | 43,142,309) | 41,033,858) | 40,466,332) | 39,120,015) | 38,707,144) | 37,147,402) | 38,169,265) | ||||||||
| Profitability Ratio | |||||||||||||||||||||||||||||||||||
| Gross profit margin1 | 3.42% | 3.41% | 3.47% | 3.48% | 3.55% | 3.59% | 3.42% | 3.24% | 3.04% | 2.83% | 2.78% | 2.73% | 2.70% | 2.70% | 2.79% | 2.86% | 2.81% | 2.84% | 2.78% | 2.75% | 2.90% | 2.90% | 2.97% | 2.97% | — | — | — | ||||||||
| Benchmarks | |||||||||||||||||||||||||||||||||||
| Gross Profit Margin, Competitors2 | |||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 49.97% | 50.23% | 50.66% | 51.54% | 52.60% | 53.54% | 52.44% | 52.21% | 52.01% | 50.69% | 51.25% | 50.49% | 50.18% | 50.97% | 52.13% | 52.46% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 12.28% | 12.19% | 12.39% | 12.44% | 12.39% | 12.40% | 12.30% | 12.41% | 12.77% | 13.13% | 14.04% | 14.43% | 15.05% | 15.49% | 15.30% | 15.57% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 15.34% | 15.69% | 16.16% | 16.62% | 16.94% | 17.12% | 17.35% | 17.48% | 17.35% | 17.43% | 17.99% | 18.01% | 18.10% | 18.16% | 17.51% | 17.41% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 16.86% | 16.89% | 16.90% | 16.79% | 16.85% | 16.79% | 16.89% | 17.09% | 17.30% | 17.57% | 19.38% | 19.71% | 20.18% | 20.43% | 18.70% | 18.77% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 66.61% | 66.74% | 66.86% | 67.44% | 67.77% | 68.16% | 68.84% | 69.32% | 69.12% | 68.69% | 66.48% | 65.65% | 66.44% | 67.07% | 69.04% | 69.45% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 66.43% | 67.21% | 67.61% | 67.98% | 67.89% | 67.39% | 66.53% | 65.19% | 63.85% | 64.57% | 65.76% | 67.41% | 68.96% | 69.22% | 69.62% | 70.04% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 24.16% | 24.08% | 24.20% | 24.09% | 23.74% | 23.51% | 23.31% | 23.60% | 23.75% | 23.80% | 25.79% | 25.62% | 25.83% | 25.95% | 23.52% | 23.19% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31).
1 Q3 2023 Calculation
Gross profit margin = 100
× (Gross profitQ3 2023
+ Gross profitQ2 2023
+ Gross profitQ1 2023
+ Gross profitQ4 2022)
÷ (RevenueQ3 2023
+ RevenueQ2 2023
+ RevenueQ1 2023
+ RevenueQ4 2022)
= 100 × (2,264,646 + 2,295,442 + 2,145,953 + 1,985,559)
÷ (66,947,043 + 63,457,205 + 62,846,832 + 61,174,149)
= 3.42%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | AmerisourceBergen Corp. gross profit margin ratio deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023. |
Operating Profit Margin
AmerisourceBergen Corp., operating profit margin calculation (quarterly data)
| Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||||||||
| Operating income (loss) | 670,128) | 560,519) | 633,143) | 454,519) | 487,297) | 780,157) | 644,405) | 561,895) | 620,727) | 624,347) | 547,228) | (6,113,137) | 404,831) | 309,515) | 263,437) | 179,841) | 406,694) | 47,565) | 477,823) | 154,097) | 389,195) | 481,420) | 418,973) | (135,002) | 170,376) | 624,981) | 399,987) | ||||||||
| Revenue | 66,947,043) | 63,457,205) | 62,846,832) | 61,174,149) | 60,064,601) | 57,719,446) | 59,628,810) | 58,912,421) | 53,405,695) | 49,154,171) | 52,516,556) | 49,244,768) | 45,366,777) | 47,417,639) | 47,864,742) | 45,637,802) | 45,239,265) | 43,319,602) | 45,392,452) | 43,297,136) | 43,142,309) | 41,033,858) | 40,466,332) | 39,120,015) | 38,707,144) | 37,147,402) | 38,169,265) | ||||||||
| Profitability Ratio | |||||||||||||||||||||||||||||||||||
| Operating profit margin1 | 0.91% | 0.86% | 0.97% | 0.99% | 1.05% | 1.14% | 1.11% | 1.10% | -2.11% | -2.31% | -2.49% | -2.70% | 0.62% | 0.62% | 0.49% | 0.62% | 0.61% | 0.61% | 0.87% | 0.86% | 0.71% | 0.59% | 0.69% | 0.69% | — | — | — | ||||||||
| Benchmarks | |||||||||||||||||||||||||||||||||||
| Operating Profit Margin, Competitors2 | |||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 15.02% | 15.23% | 16.77% | 19.16% | 20.95% | 22.42% | 20.73% | 19.56% | 20.04% | 18.46% | 17.97% | 15.48% | 13.39% | 12.78% | 14.18% | 14.21% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 4.34% | 4.38% | 4.54% | 4.69% | 4.59% | 4.71% | 4.64% | 4.60% | 4.59% | 4.57% | 4.98% | 5.12% | 5.37% | 5.47% | 5.18% | 5.31% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 4.04% | 1.88% | 2.33% | 2.41% | 2.02% | 4.35% | 4.39% | 4.54% | 4.75% | 4.93% | 5.19% | 5.19% | 5.44% | 5.36% | 4.89% | 4.69% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 4.58% | 4.96% | 4.99% | 4.94% | 5.01% | 5.07% | 5.10% | 5.15% | 4.91% | 3.68% | 4.83% | 4.97% | 5.59% | 6.99% | 5.47% | 5.49% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 24.66% | 24.34% | 24.21% | 25.35% | 27.05% | 28.48% | 30.69% | 31.89% | 32.55% | 31.27% | 26.01% | 24.09% | 23.95% | 25.86% | 30.52% | 30.69% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 18.17% | 19.02% | 19.37% | 18.15% | 17.89% | 16.68% | 14.78% | 14.89% | 11.44% | 12.77% | 14.25% | 16.57% | 20.67% | 20.47% | 21.25% | 20.51% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 8.86% | 8.83% | 8.87% | 8.83% | 8.65% | 8.32% | 8.19% | 8.40% | 7.91% | 7.73% | 9.24% | 8.76% | 9.55% | 9.89% | 8.12% | 8.19% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31).
1 Q3 2023 Calculation
Operating profit margin = 100
× (Operating income (loss)Q3 2023
+ Operating income (loss)Q2 2023
+ Operating income (loss)Q1 2023
+ Operating income (loss)Q4 2022)
÷ (RevenueQ3 2023
+ RevenueQ2 2023
+ RevenueQ1 2023
+ RevenueQ4 2022)
= 100 × (670,128 + 560,519 + 633,143 + 454,519)
÷ (66,947,043 + 63,457,205 + 62,846,832 + 61,174,149)
= 0.91%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | AmerisourceBergen Corp. operating profit margin ratio deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023. |
Net Profit Margin
AmerisourceBergen Corp., net profit margin calculation (quarterly data)
| Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||||||||
| Net income (loss) attributable to AmerisourceBergen Corporation | 479,581) | 435,402) | 479,745) | 294,737) | 406,964) | 548,014) | 449,105) | 437,698) | 292,122) | 435,267) | 374,845) | (4,846,072) | 289,439) | 960,277) | 187,640) | 132,619) | 301,959) | 27,135) | 393,652) | 233,288) | 275,809) | 287,455) | 861,853) | (344,587) | 50,352) | 411,473) | 247,246) | ||||||||
| Revenue | 66,947,043) | 63,457,205) | 62,846,832) | 61,174,149) | 60,064,601) | 57,719,446) | 59,628,810) | 58,912,421) | 53,405,695) | 49,154,171) | 52,516,556) | 49,244,768) | 45,366,777) | 47,417,639) | 47,864,742) | 45,637,802) | 45,239,265) | 43,319,602) | 45,392,452) | 43,297,136) | 43,142,309) | 41,033,858) | 40,466,332) | 39,120,015) | 38,707,144) | 37,147,402) | 38,169,265) | ||||||||
| Profitability Ratio | |||||||||||||||||||||||||||||||||||
| Net profit margin1 | 0.66% | 0.65% | 0.72% | 0.71% | 0.78% | 0.75% | 0.73% | 0.72% | -1.83% | -1.91% | -1.66% | -1.80% | 0.84% | 0.85% | 0.36% | 0.48% | 0.54% | 0.53% | 0.69% | 0.99% | 0.66% | 0.54% | 0.63% | 0.24% | — | — | — | ||||||||
| Benchmarks | |||||||||||||||||||||||||||||||||||
| Net Profit Margin, Competitors2 | |||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 12.92% | 12.83% | 13.98% | 15.88% | 17.52% | 18.78% | 17.35% | 16.42% | 17.12% | 15.85% | 15.33% | 12.99% | 10.50% | 9.89% | 11.15% | 11.56% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 2.81% | 3.59% | 3.71% | 3.72% | 3.69% | 3.08% | 3.07% | 3.11% | 4.97% | 4.93% | 5.22% | 5.31% | 3.40% | 3.43% | 3.22% | 3.35% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 2.48% | 0.86% | 1.20% | 1.29% | 1.00% | 2.66% | 2.68% | 2.72% | 2.67% | 2.60% | 2.74% | 2.68% | 3.00% | 3.14% | 2.77% | 2.59% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 3.63% | 3.89% | 3.89% | 3.87% | 4.09% | 4.13% | 4.37% | 4.46% | 4.17% | 3.32% | 3.82% | 3.78% | 4.26% | 5.27% | 4.42% | 4.66% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 22.14% | 21.38% | 20.40% | 21.25% | 22.52% | 24.05% | 27.84% | 29.85% | 30.78% | 31.43% | 25.78% | 24.33% | 24.45% | 26.07% | 30.11% | 30.80% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 13.20% | 14.03% | 16.75% | 15.90% | 15.46% | 14.79% | 12.29% | 11.97% | 10.36% | 12.69% | 15.80% | 16.56% | 17.11% | 15.11% | 14.41% | 15.16% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 6.09% | 6.11% | 6.21% | 6.25% | 6.21% | 5.99% | 5.91% | 6.06% | 5.56% | 5.37% | 6.46% | 6.03% | 6.66% | 6.94% | 5.63% | 5.76% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31).
1 Q3 2023 Calculation
Net profit margin = 100
× (Net income (loss) attributable to AmerisourceBergen CorporationQ3 2023
+ Net income (loss) attributable to AmerisourceBergen CorporationQ2 2023
+ Net income (loss) attributable to AmerisourceBergen CorporationQ1 2023
+ Net income (loss) attributable to AmerisourceBergen CorporationQ4 2022)
÷ (RevenueQ3 2023
+ RevenueQ2 2023
+ RevenueQ1 2023
+ RevenueQ4 2022)
= 100 × (479,581 + 435,402 + 479,745 + 294,737)
÷ (66,947,043 + 63,457,205 + 62,846,832 + 61,174,149)
= 0.66%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | AmerisourceBergen Corp. net profit margin ratio deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023. |
Return on Equity (ROE)
AmerisourceBergen Corp., ROE calculation (quarterly data)
| Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||||||||
| Net income (loss) attributable to AmerisourceBergen Corporation | 479,581) | 435,402) | 479,745) | 294,737) | 406,964) | 548,014) | 449,105) | 437,698) | 292,122) | 435,267) | 374,845) | (4,846,072) | 289,439) | 960,277) | 187,640) | 132,619) | 301,959) | 27,135) | 393,652) | 233,288) | 275,809) | 287,455) | 861,853) | (344,587) | 50,352) | 411,473) | 247,246) | ||||||||
| Total AmerisourceBergen Corporation stockholders’ equity (deficit) | 686,018) | 281,686) | (178,131) | (211,559) | 224,299) | 550,309) | 241,546) | 223,354) | 37,962) | (281,756) | (697,222) | (1,018,924) | 3,857,252) | 3,590,590) | 2,954,626) | 2,878,917) | 2,989,422) | 2,921,215) | 3,048,453) | 2,932,824) | 3,097,821) | 3,187,550) | 2,874,582) | 2,064,461) | 2,553,514) | 2,529,292) | 2,116,557) | ||||||||
| Profitability Ratio | |||||||||||||||||||||||||||||||||||
| ROE1 | 246.27% | 573.99% | — | — | 821.13% | 313.81% | 668.28% | 689.46% | -9,862.07% | — | — | — | 40.70% | 44.07% | 21.98% | 29.71% | 31.98% | 31.83% | 39.04% | 56.55% | 34.88% | 26.83% | 34.06% | 17.66% | — | — | — | ||||||||
| Benchmarks | |||||||||||||||||||||||||||||||||||
| ROE, Competitors2 | |||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 13.77% | 13.88% | 15.68% | 18.90% | 22.11% | 23.44% | 21.82% | 19.75% | 21.04% | 18.86% | 17.06% | 13.71% | 10.78% | 10.17% | 11.84% | 11.86% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 11.61% | 14.64% | 15.17% | 14.86% | 14.69% | 11.94% | 11.69% | 11.39% | 17.68% | 16.73% | 17.52% | 16.81% | 11.03% | 11.11% | 10.91% | 11.26% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 11.57% | 4.02% | 5.57% | 5.84% | 4.46% | 10.86% | 10.83% | 10.54% | 10.20% | 9.83% | 10.44% | 10.35% | 11.56% | 12.14% | 11.08% | 10.39% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 15.82% | 16.78% | 16.62% | 16.59% | 17.26% | 17.04% | 17.36% | 16.93% | 15.44% | 12.10% | 13.92% | 13.77% | 14.61% | 17.17% | 15.08% | 15.15% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 12.10% | 12.00% | 11.70% | 11.98% | 11.97% | 11.93% | 13.58% | 14.32% | 14.80% | 14.97% | 11.56% | 10.90% | 11.38% | 13.00% | 16.30% | 16.69% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 7.90% | 8.33% | 9.88% | 9.59% | 9.35% | 9.05% | 7.54% | 7.01% | 5.70% | 7.05% | 8.77% | 9.44% | 10.26% | 9.23% | 8.78% | 9.25% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 25.67% | 25.63% | 25.46% | 25.87% | 26.03% | 25.07% | 23.98% | 24.09% | 21.95% | 21.03% | 25.42% | 23.52% | 25.65% | 26.87% | 24.14% | 24.02% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31).
1 Q3 2023 Calculation
ROE = 100
× (Net income (loss) attributable to AmerisourceBergen CorporationQ3 2023
+ Net income (loss) attributable to AmerisourceBergen CorporationQ2 2023
+ Net income (loss) attributable to AmerisourceBergen CorporationQ1 2023
+ Net income (loss) attributable to AmerisourceBergen CorporationQ4 2022)
÷ Total AmerisourceBergen Corporation stockholders’ equity (deficit)
= 100 × (479,581 + 435,402 + 479,745 + 294,737)
÷ 686,018 = 246.27%
2 Click competitor name to see calculations.
Return on Assets (ROA)
AmerisourceBergen Corp., ROA calculation (quarterly data)
| Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||||||||
| Net income (loss) attributable to AmerisourceBergen Corporation | 479,581) | 435,402) | 479,745) | 294,737) | 406,964) | 548,014) | 449,105) | 437,698) | 292,122) | 435,267) | 374,845) | (4,846,072) | 289,439) | 960,277) | 187,640) | 132,619) | 301,959) | 27,135) | 393,652) | 233,288) | 275,809) | 287,455) | 861,853) | (344,587) | 50,352) | 411,473) | 247,246) | ||||||||
| Total assets | 61,177,196) | 58,766,183) | 57,906,893) | 56,560,616) | 57,173,630) | 57,308,153) | 57,577,564) | 57,337,805) | 55,930,936) | 47,003,250) | 45,846,768) | 44,274,830) | 40,789,703) | 42,042,262) | 40,016,738) | 39,171,980) | 38,478,538) | 38,810,310) | 39,267,823) | 37,669,838) | 38,309,592) | 38,395,732) | 36,361,510) | 35,316,470) | 34,654,010) | 34,397,013) | 33,919,272) | ||||||||
| Profitability Ratio | |||||||||||||||||||||||||||||||||||
| ROA1 | 2.76% | 2.75% | 2.99% | 3.00% | 3.22% | 3.01% | 2.80% | 2.69% | -6.69% | -7.97% | -7.03% | -7.70% | 3.85% | 3.76% | 1.62% | 2.18% | 2.48% | 2.40% | 3.03% | 4.40% | 2.82% | 2.23% | 2.69% | 1.03% | — | — | — | ||||||||
| Benchmarks | |||||||||||||||||||||||||||||||||||
| ROA, Competitors2 | |||||||||||||||||||||||||||||||||||
| Abbott Laboratories | 7.16% | 7.04% | 7.87% | 9.31% | 10.84% | 11.53% | 10.44% | 9.40% | 9.82% | 8.70% | 7.86% | 6.20% | 4.90% | 4.52% | 5.36% | 5.43% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Cigna Group | 3.54% | 4.43% | 4.56% | 4.63% | 4.59% | 3.59% | 3.53% | 3.46% | 5.44% | 5.29% | 5.55% | 5.44% | 3.31% | 3.30% | 3.18% | 3.28% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| CVS Health Corp. | 3.42% | 1.17% | 1.66% | 1.82% | 1.36% | 3.55% | 3.43% | 3.39% | 3.23% | 3.12% | 3.22% | 3.11% | 3.41% | 3.51% | 3.13% | 2.98% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Elevance Health Inc. | 5.50% | 5.87% | 5.69% | 5.86% | 6.03% | 6.05% | 6.21% | 6.26% | 5.63% | 4.40% | 4.93% | 5.28% | 5.72% | 6.72% | 5.80% | 6.21% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Intuitive Surgical Inc. | 10.31% | 10.25% | 10.05% | 10.19% | 10.39% | 10.47% | 12.02% | 12.58% | 13.06% | 13.20% | 10.17% | 9.50% | 9.92% | 11.24% | 14.02% | 14.17% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| Medtronic PLC | 4.32% | 4.63% | 5.79% | 5.54% | 5.35% | 5.13% | 4.23% | 3.87% | 2.97% | 3.69% | 4.70% | 5.28% | 5.73% | 5.13% | 4.84% | 5.16% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
| UnitedHealth Group Inc. | 7.69% | 7.53% | 7.30% | 8.19% | 7.99% | 7.93% | 7.89% | 8.15% | 7.24% | 6.90% | 8.23% | 7.81% | 8.76% | 8.88% | 7.27% | 7.96% | — | — | — | — | — | — | — | — | — | — | — | ||||||||
Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31).
1 Q3 2023 Calculation
ROA = 100
× (Net income (loss) attributable to AmerisourceBergen CorporationQ3 2023
+ Net income (loss) attributable to AmerisourceBergen CorporationQ2 2023
+ Net income (loss) attributable to AmerisourceBergen CorporationQ1 2023
+ Net income (loss) attributable to AmerisourceBergen CorporationQ4 2022)
÷ Total assets
= 100 × (479,581 + 435,402 + 479,745 + 294,737)
÷ 61,177,196 = 2.76%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | AmerisourceBergen Corp. ROA deteriorated from Q1 2023 to Q2 2023 but then slightly improved from Q2 2023 to Q3 2023. |